Updates on community acquired pneumonia management in the ICU

GB Nair, MS Niederman - Pharmacology & therapeutics, 2021 - Elsevier
While the world is grappling with the consequences of a global pandemic related to SARS-
CoV-2 causing severe pneumonia, available evidence points to bacterial infection with …

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

A Zumla, M Rao, RS Wallis, SHE Kaufmann… - The Lancet Infectious …, 2016 - thelancet.com
Despite extensive global efforts in the fight against killer infectious diseases, they still cause
one in four deaths worldwide and are important causes of long-term functional disability …

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016

A Rhodes, LE Evans, W Alhazzani, MM Levy… - Intensive care …, 2017 - Springer
Objective To provide an update to “Surviving Sepsis Campaign Guidelines for Management
of Sepsis and Septic Shock: 2012”. Design A consensus committee of 55 international …

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

RP Dellinger, MM Levy, A Rhodes, D Annane… - Critical care …, 2013 - journals.lww.com
Objective: To provide an update to the “Surviving Sepsis Campaign Guidelines for
Management of Severe Sepsis and Septic Shock,” last published in 2008. Design: A …

Guidelines for the management of adult lower respiratory tract infections‐Full version

M Woodhead, F Blasi, S Ewig, J Garau… - Clinical microbiology …, 2011 - Wiley Online Library
Clin Microbiol Infect 2011; 17 (Suppl. 6): E1–E59 Abstract This document is an update of
Guidelines published in 2005 and now includes scientific publications through to May 2010 …

Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis

Y Yang, Z Zhang, S Li, X Ye, X Li, K He - Fitoterapia, 2014 - Elsevier
Herbal medicine, especially traditional Chinese medicine and Ayurvedic medicine have
played and still play an important role in fighting against various diseases. Emerging clinical …

Community-acquired bacterial pneumonia in adults: An update

VK Eshwara, C Mukhopadhyay… - Indian Journal of Medical …, 2020 - journals.lww.com
Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity
with important clinical impact across the globe. India accounts for 23 per cent of global …

β-Lactam monotherapy vs β-lactam–macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial

N Garin, D Genné, S Carballo, C Chuard… - JAMA internal …, 2014 - jamanetwork.com
Importance The clinical benefit of adding a macrolide to a β-lactam for empirical treatment of
moderately severe community-acquired pneumonia remains controversial. Objective To test …

A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic …

A Kumar, N Safdar, S Kethireddy… - Critical care …, 2010 - journals.lww.com
Objective: To assess whether a potential benefit with combination antibiotic therapy is
restricted to the most critically ill subset of patients, particularly those with septic shock. Data …

Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia

I Martin-Loeches, T Lisboa, A Rodriguez… - Intensive care …, 2010 - Springer
Objective To assess the effect on survival of macrolides or fluoroquinolones in intubated
patients admitted to the intensive care unit (ICU) with severe community-acquired …